StonvexLoading…
StonvexStonvexStonvexCore line items from IMNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $6.94M | $6.94M | $6.94M |
Operating Income | $-59.33M | $-224.11M | $-151.25M | $-91.11M |
Net Income | $-53.84M | $-212.39M | $-142.49M | $-43.40M |
EPS (Diluted) | $-0.48 | $-2.43 | $-1.68 | $-1.02 |
Total Assets | $619.79M | $683.19M | $299.38M | $296.29M |
Total Liabilities | $31.11M | $48.84M | $35.46M | $27.02M |
Cash & Equivalents | $582.69M | $653.48M | $272.64M | $143.88M |
Free Cash Flow OCF − CapEx | $-61.64M | $-200.60M | $-148.65M | $-107.03M |
Shares Outstanding | 113.17M | 113.13M | 91.71M | 87.01M |